5-AMINOSALICYLIC ACID (5-ASA) RETENTION ENEMATA FOR LONG-TERM THERAPY OF INFLAMMATORY BOWEL-DISEASE (IBD)

被引：0
|
作者：
WYMAN, JB [1 ]
NUNEZ, JF [1 ]
PARENT, K [1 ]
NORFLEET, RG [1 ]
KIRCHNER, JP [1 ]
RYAN, ME [1 ]
RHODES, RA [1 ]
机构：
[1] MARSHFIELD CLIN,GASTROENTEROL SECT,MARSHFIELD,WI 54449
来源：
GASTROENTEROLOGY | 1985年 / 88卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1636 / 1636
页数：1
相关论文
共 50 条
  • [1] 5-aminosalicylic acid (5-ASA) therapy is associated with renal failure in patients with inflammatory bowel disease (IBD).
    Elseviers, MM
    Nouwen, EJ
    DeBroe, ME
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A0590 - A0590
  • [2] 5-Aminosalicylic acid (5-Asa) therapy is associated with a decreased risk of polyps in inflammatory bowel disease (IBD) patients
    Rubin, DT
    Terdiman, JP
    Blumentals, WA
    Ullman, T
    GASTROENTEROLOGY, 2005, 128 (04) : A571 - A571
  • [3] Microproteinuria in patients with inflammatory bowel disease (IBD): Is it associated with the disease activity or the treatment with 5-aminosalicylic acid (5-ASA)?
    Poulou, A
    Goumas, K
    Dandakis, D
    Tyrmpas, I
    Panagiotaki, M
    Papatheodoridis, G
    Terzi, T
    Terzoglou, C
    Georgouli, A
    Liosis, I
    Soutos, D
    GASTROENTEROLOGY, 2004, 126 (04) : A469 - A469
  • [4] Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease -: A systematic review
    Gisbert, JP
    Gomollón, F
    Maté, J
    Pajares, JM
    DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (03) : 471 - 488
  • [5] 5-AMINOSALICYLIC ACID FOR THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    RASMUSSEN, SN
    BINDER, V
    MAIER, K
    BONDESEN, S
    FISCHER, C
    KLOTZ, U
    HANSEN, SH
    HVIDBERG, EF
    GASTROENTEROLOGY, 1984, 87 (02) : 480 - 480
  • [6] REVIEW: Role of 5-Aminosalicylic Acid (5-ASA) in Treatment of Inflammatory Bowel Disease: A Systemic Review
    Javier P. Gisbert
    Fernando Gomollón
    José Maté
    José María Pajares
    Digestive Diseases and Sciences, 2002, 47 : 471 - 488
  • [7] OVERVIEW OF 5-ASA IN THERAPY OF INFLAMMATORY BOWEL-DISEASE
    WILLIAMS, CN
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1994, 8 (06): : 379 - 382
  • [8] 5-AMINOSALICYLIC ACID IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    BONDESEN, S
    RASMUSSEN, SN
    RASKMADSEN, J
    NIELSEN, OH
    LAURITSEN, K
    BINDER, V
    HANSEN, SH
    HVIDBERG, EF
    ACTA MEDICA SCANDINAVICA, 1987, 221 (03): : 227 - 242
  • [9] Possible protective effect of 5-aminosalicylic acid (5-ASA) on Helicobacter pylori (Hp) infection in patients with inflammatory bowel disease (IBD).
    Piodi, LP
    Rocchia, C
    Boarino, V
    Baldassarri, A
    Quatrini, M
    GASTROENTEROLOGY, 2000, 118 (04) : A1364 - A1364
  • [10] Possible protective effect of 5-aminosalicylic acid (5-ASA) on Helicobacter pylori (Hp) infection in patients with inflammatory bowel disease (IBD).
    Piodi, LP
    Rocchia, C
    Baldassarri, AR
    Quatrini, M
    GUT, 2000, 47 : A108 - A108
12345